01 1MSN Laboratories Private Limited
02 1Olon S.p.A.
03 1Olon SpA
01 3Clidinium Bromide
01 1India
02 2Italy
NDC Package Code : 14501-0034
Start Marketing Date : 2018-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0509
Start Marketing Date : 2020-03-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0014
Start Marketing Date : 2012-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A CLIDINIUM BROMIDE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CLIDINIUM BROMIDE, including repackagers and relabelers. The FDA regulates CLIDINIUM BROMIDE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CLIDINIUM BROMIDE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CLIDINIUM BROMIDE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CLIDINIUM BROMIDE supplier is an individual or a company that provides CLIDINIUM BROMIDE active pharmaceutical ingredient (API) or CLIDINIUM BROMIDE finished formulations upon request. The CLIDINIUM BROMIDE suppliers may include CLIDINIUM BROMIDE API manufacturers, exporters, distributors and traders.
click here to find a list of CLIDINIUM BROMIDE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CLIDINIUM BROMIDE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CLIDINIUM BROMIDE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CLIDINIUM BROMIDE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CLIDINIUM BROMIDE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CLIDINIUM BROMIDE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CLIDINIUM BROMIDE suppliers with NDC on PharmaCompass.
We have 2 companies offering CLIDINIUM BROMIDE
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
